Skip to main content
Top
Published in: Intensive Care Medicine 1/2006

01-01-2006 | Editorial

Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ

Authors: P. Asfar, P. Radermacher, B. Hauser

Published in: Intensive Care Medicine | Issue 1/2006

Login to get access

Excerpt

Albeit V1a receptor agonists are currently proposed to treat vasodilatory shock [1], their use is still controversially discussed, because these compounds may induce excessive vasoconstriction in some vascular beds that is not counterbalanced by a positive inotropic effect. Since the splanchnic circulation is thought to play a pivotal role for the development of multiple organ dysfunction, assessing the effects of V1a agonists in this vascular bed is mandatory. …
Literature
1.
2.
go back to reference Knotzer H, Maier S, Dunser M, Hasibeder WR, Hausdorfer M, Brandner J, Togersen C, Ulmer H, Friesenecker B, Iannetti C, Pajk W (2005) Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxmic pig model. Int Care Med. DOI: 10.1007/s00134-005-2858-z Knotzer H, Maier S, Dunser M, Hasibeder WR, Hausdorfer M, Brandner J, Togersen C, Ulmer H, Friesenecker B, Iannetti C, Pajk W (2005) Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxmic pig model. Int Care Med. DOI: 10.​1007/​s00134-005-2858-z
3.
go back to reference Knotzer H, Pajk W, Maier S, Ladurner R, A. K, Wenzel V, Dunser MW, Ulmer H, Hasibeder WR (2005) Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension. Am J Physiol Heart Circ Physiol 289:H168–173CrossRefPubMed Knotzer H, Pajk W, Maier S, Ladurner R, A. K, Wenzel V, Dunser MW, Ulmer H, Hasibeder WR (2005) Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension. Am J Physiol Heart Circ Physiol 289:H168–173CrossRefPubMed
4.
go back to reference Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL (2003) Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 168:481–486CrossRefPubMed Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL (2003) Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 168:481–486CrossRefPubMed
5.
go back to reference Asfar P, Hauser B, Ivanyi Z, Ehrmann U, Kick J, Albicini M, Vogt J, Wachter U, Bruckner UB, Radermacher P, Bracht H (2005) Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 33:373–380CrossRefPubMed Asfar P, Hauser B, Ivanyi Z, Ehrmann U, Kick J, Albicini M, Vogt J, Wachter U, Bruckner UB, Radermacher P, Bracht H (2005) Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 33:373–380CrossRefPubMed
6.
go back to reference Asfar P, Pierrot M, Veal N, Moal F, Oberti F, Croquet V, Douay O, Gallois Y, Saumet JL, Alquier P, Calès P (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31:215–220CrossRefPubMed Asfar P, Pierrot M, Veal N, Moal F, Oberti F, Croquet V, Douay O, Gallois Y, Saumet JL, Alquier P, Calès P (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31:215–220CrossRefPubMed
7.
go back to reference Westphal M, Freise H, Kehrel BE, Bone HG, Van Aken H, Sielenkamper AW (2004) Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194–200CrossRefPubMed Westphal M, Freise H, Kehrel BE, Bone HG, Van Aken H, Sielenkamper AW (2004) Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194–200CrossRefPubMed
8.
go back to reference Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97:1756–1763CrossRefPubMed Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97:1756–1763CrossRefPubMed
9.
go back to reference Malay MB, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC Jr, Sciacca RR, Oliver JA, Landry DW (2004) Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 32:1327–1331CrossRefPubMed Malay MB, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC Jr, Sciacca RR, Oliver JA, Landry DW (2004) Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 32:1327–1331CrossRefPubMed
10.
go back to reference van Haren FM, Rozendaal FW, van der Hoeven JG (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124:2256–2260CrossRefPubMed van Haren FM, Rozendaal FW, van der Hoeven JG (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124:2256–2260CrossRefPubMed
11.
go back to reference Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646–2650CrossRefPubMed Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646–2650CrossRefPubMed
12.
go back to reference Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Int Care Med 30:597–604CrossRef Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Int Care Med 30:597–604CrossRef
13.
go back to reference Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313–2319CrossRefPubMed Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313–2319CrossRefPubMed
14.
go back to reference Dubois M, De Backer D, Creteur J, Anane S, Vincent JL (2003) Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Int Care Med 29:1020–1023 Dubois M, De Backer D, Creteur J, Anane S, Vincent JL (2003) Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Int Care Med 29:1020–1023
15.
go back to reference Boerma E, Van der Voort P, Ince C (2005) Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock. Acta Anaesthesiol Scand 49:1387–1390CrossRefPubMed Boerma E, Van der Voort P, Ince C (2005) Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock. Acta Anaesthesiol Scand 49:1387–1390CrossRefPubMed
Metadata
Title
Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ
Authors
P. Asfar
P. Radermacher
B. Hauser
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 1/2006
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-2867-y

Other articles of this Issue 1/2006

Intensive Care Medicine 1/2006 Go to the issue